|
Volumn 6, Issue 12, 2005, Pages 1207-1210
|
Breaking down the barriers to cancer immunotherapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADJUVANT;
ALPHA GALACTOSYLCERAMIDE;
ANTIBODY;
CANCER VACCINE;
CPG OLIGODEOXYNUCLEOTIDE;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY;
DENILEUKIN DIFTITOX;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
IMIQUIMOD;
NATURAL KILLER CELL RECEPTOR NKG2D;
RECEPTOR ANTIBODY;
UNCLASSIFIED DRUG;
CANCER IMMUNOTHERAPY;
CELL ACTIVATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
IMMUNOCOMPETENT CELL;
INNATE IMMUNITY;
NONHUMAN;
PRIORITY JOURNAL;
REGULATORY MECHANISM;
TUMOR CELL;
ANIMALS;
HUMANS;
IMMUNITY, NATURAL;
IMMUNOTHERAPY;
NEOPLASMS;
|
EID: 30044437872
PISSN: 15292908
EISSN: 15292916
Source Type: Journal
DOI: 10.1038/ni1205-1207 Document Type: Conference Paper |
Times cited : (56)
|
References (14)
|